Economic Impact of Migraine and Other Episodic Headaches in France: Data from the GRIM2000 Study

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.22, Iss.15, 2004-01, pp. : 985-999

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Calcitonin Gene-Related Peptide Antagonists as Treatments of Migraine and Other Primary Headaches

By Goadsby Peter J.

Drugs, Vol. 65, Iss. 18, 2005-01 ,pp. : 2557-2567

Adis International

Access to resources Recommend Favorite

Topiramate reverts chronic migraine to episodic migraine in patients with medication overuse

Inpharma, Vol. 1, Iss. 1559, 2006-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

OnabotulinumtoxinA (BOTOX®): A Review of its Use in the Prophylaxis of Headaches in Adults with Chronic Migraine

By Frampton James E.

Drugs, Vol. 72, Iss. 6, 2012-04 ,pp. : 825-845

Adis International

Access to resources Recommend Favorite

OnabotulinumtoxinA (BOTOX®): A Guide to Its Use in Preventing Headaches in Adults with Chronic Migraine

By Lyseng-Williamson Katherine A. Frampton James E.

CNS Drugs, Vol. 26, Iss. 8, 2012-08 ,pp. : 717-723

Adis International

Access to resources Recommend Favorite

Clinical and Economic Comparison of Frovatriptan Versus other Oral Triptans in the Treatment of Acute Migraine in the Real-World Setting

By Guidotti Mario

Clinical Drug Investigation, Vol. 29, Iss. 11, 2009-11 ,pp. : 693-702

Adis International

Access to resources Recommend Favorite